Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
May 26  •  12:39PM ET
15.95
Dollar change
+0.85
Percentage change
5.63
%
Index
-
P/E
71.30
EPS (ttm)
0.22
Insider Own
26.55%
Shs Outstand
40.03M
Perf Week
7.19%
Market Cap
638.64M
Forward P/E
55.64
EPS next Y
0.29
Insider Trans
0.00%
Shs Float
29.42M
Perf Month
-2.57%
Enterprise Value
586.46M
PEG
3.36
EPS next Q
0.04
Inst Own
16.43%
Perf Quarter
30.68%
Income
8.82M
P/S
11.28
EPS this Y
7.41%
Inst Trans
2.35%
Perf Half Y
120.00%
Sales
56.60M
P/B
8.42
EPS next Y
48.28%
ROA
8.12%
Perf YTD
67.72%
Book/sh
1.89
P/C
10.84
EPS next 5Y
16.55%
ROE
12.64%
52W High
17.35 -8.08%
Perf Year
197.30%
Cash/sh
1.47
P/FCF
49.74
EPS past 3/5Y
- -
ROIC
10.84%
52W Low
5.01 218.68%
Perf 3Y
1998.68%
Dividend Est.
-
EV/EBITDA
79.25
Sales past 3/5Y
24.82% 18.84%
Gross Margin
75.51%
Volatility
2.91% 3.75%
Perf 5Y
188.17%
Dividend TTM
-
EV/Sales
10.36
EPS Y/Y TTM
109.31%
Oper. Margin
10.21%
ATR (14)
0.70
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
3.04
Sales Y/Y TTM
30.18%
Profit Margin
15.58%
RSI (14)
54.29
Dividend Gr. 3/5Y
- -
Current Ratio
3.34
EPS Q/Q
186.43%
SMA20
-0.57%
Beta
1.21
Payout
0.00%
Debt/Eq
0.09
Sales Q/Q
34.97%
SMA50
6.63%
Rel Volume
0.90
Prev Close
15.10
Employees
129
LT Debt/Eq
0.07
SMA200
49.48%
Avg Volume
165.67K
Price
15.95
IPO
Apr 17, 2019
Option/Short
Yes / Yes
Trades
Volume
76,399
Change
5.63%
Date Action Analyst Rating Change Price Target Change
Nov-16-23Downgrade Raymond James Outperform → Mkt Perform
Mar-03-22Initiated Loop Capital Buy $15
Jul-19-21Initiated H.C. Wainwright Buy $17
Apr-20-21Initiated Northland Capital Outperform $15
May-13-19Initiated Raymond James Outperform $14
May-13-19Initiated Oppenheimer Outperform
May-13-19Initiated Ladenburg Thalmann Buy
May-13-19Initiated Cantor Fitzgerald Overweight $17
May-18-26 07:30AM
May-13-26 07:02PM
07:30AM
Apr-29-26 08:00AM
Apr-15-26 07:30AM
08:02PM Loading…
Apr-14-26 08:02PM
Apr-13-26 08:03PM
08:00AM
Mar-26-26 07:30AM
Mar-19-26 07:30AM
Mar-11-26 03:01PM
07:30AM
Mar-10-26 09:24AM
Mar-05-26 09:30AM
Mar-04-26 07:30AM
08:00AM Loading…
Feb-25-26 08:00AM
Feb-23-26 08:00AM
Feb-19-26 07:30AM
Feb-18-26 07:30AM
Feb-17-26 07:30AM
Jan-21-26 07:30AM
Jan-12-26 07:30AM
Jan-07-26 07:30AM
Dec-23-25 12:07PM
Dec-22-25 07:30AM
Dec-02-25 10:12AM
Nov-25-25 07:30AM
Nov-17-25 07:30AM
Nov-13-25 06:00AM
Nov-11-25 04:01PM
07:30AM Loading…
07:30AM
Nov-10-25 07:21AM
Nov-07-25 09:40AM
Nov-04-25 08:00AM
Oct-28-25 09:15AM
08:00AM
Oct-27-25 07:30AM
Oct-21-25 09:40AM
08:28AM
Sep-26-25 01:29PM
Sep-17-25 10:41AM
Sep-16-25 08:30AM
Aug-22-25 01:30PM
Aug-21-25 09:32AM
07:30AM
Aug-20-25 09:15AM
07:30AM
Aug-19-25 09:40AM
09:15AM
Aug-18-25 12:20PM
09:55AM
Aug-13-25 07:30AM
Aug-12-25 09:25AM
Jul-30-25 09:02AM
08:00AM
Jul-22-25 08:07AM
Jul-15-25 08:50AM
Jun-26-25 08:36AM
Jun-24-25 09:55AM
08:54AM
Jun-19-25 09:40AM
Jun-12-25 09:15AM
Jun-11-25 07:30AM
Jun-10-25 08:50AM
08:00AM
Jun-05-25 09:55AM
Jun-04-25 07:30AM
May-29-25 12:20PM
May-20-25 09:55AM
May-13-25 07:30AM
May-12-25 09:31AM
May-01-25 08:00AM
Apr-29-25 08:00AM
Apr-02-25 03:26PM
Mar-18-25 03:04PM
Mar-12-25 03:03AM
Mar-11-25 07:30AM
Mar-04-25 08:00AM
Feb-24-25 08:00AM
Feb-17-25 09:15AM
Feb-05-25 05:59PM
Jan-22-25 09:15AM
07:39AM
Jan-15-25 12:20PM
09:55AM
Dec-26-24 09:40AM
Dec-13-24 08:15AM
Dec-12-24 08:00AM
Nov-20-24 08:00AM
Nov-12-24 07:30AM
Nov-11-24 07:13AM
Oct-31-24 09:40AM
Oct-29-24 08:00AM
Oct-21-24 09:55AM
09:15AM
Oct-15-24 09:40AM
Oct-10-24 07:57AM
Oct-09-24 07:30AM
Oct-04-24 09:55AM
09:15AM
Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut in 2003 and is headquartered in Jerusalem, Israel.
Chief Executive OfficerMr. Hadar Levy
Co-Founder & Vice-ChairmanDr. David Zacut M.D.
Co-FounderProf. Abraham Zangen Ph.D.
Chief Financial OfficerMr. Ido Marom
Vice President of Medical AffairsDr. Colleen Hanlon Ph.D.